These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9779185)

  • 41. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42).
    Akiyama H; Mori H; Sahara N; Kondo H; Ikeda K; Nishimura T; Oda T; McGeer PL
    Neurochem Res; 1997 Dec; 22(12):1499-506. PubMed ID: 9357016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.
    Takahashi H; Kurashima C; Utsuyama M; Hirokawa K
    Acta Neuropathol; 1990; 80(3):260-5. PubMed ID: 1698004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease.
    Kumar-Singh S; De Jonghe C; Cruts M; Kleinert R; Wang R; Mercken M; De Strooper B; Vanderstichele H; Löfgren A; Vanderhoeven I; Backhovens H; Vanmechelen E; Kroisel PM; Van Broeckhoven C
    Hum Mol Genet; 2000 Nov; 9(18):2589-98. PubMed ID: 11063718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
    PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia.
    Jendroska K; Hoffmann OM; Patt S
    Ann N Y Acad Sci; 1997 Sep; 826():401-5. PubMed ID: 9329712
    [No Abstract]   [Full Text] [Related]  

  • 48. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
    Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
    J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease.
    Geddes JW; Tekirian TL; Mattson MP
    Neurobiol Aging; 1999; 20(1):75-9; discussion 87. PubMed ID: 10466897
    [No Abstract]   [Full Text] [Related]  

  • 52. Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study.
    Muche A; Bürger S; Arendt T; Schliebs R
    Nutr Neurosci; 2015 Jan; 18(1):1-11. PubMed ID: 24257464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.
    Selkoe DJ; Podlisny MB; Joachim CL; Vickers EA; Lee G; Fritz LC; Oltersdorf T
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7341-5. PubMed ID: 3140239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion.
    Nihashi T; Inao S; Kajita Y; Kawai T; Sugimoto T; Niwa M; Kabeya R; Hata N; Hayashi S; Yoshida J
    Acta Neurochir (Wien); 2001; 143(3):287-95. PubMed ID: 11460917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.
    Kaur G; Pawlik M; Gandy SE; Ehrlich ME; Smiley JF; Levy E
    Mol Psychiatry; 2017 Jul; 22(7):981-989. PubMed ID: 27777419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
    Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
    J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy.
    McGeer PL; Akiyama H; Kawamata T; Yamada T; Walker DG; Ishii T
    J Neurosci Res; 1992 Mar; 31(3):428-42. PubMed ID: 1640495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.
    Knauer MF; Soreghan B; Burdick D; Kosmoski J; Glabe CG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7437-41. PubMed ID: 1502155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.